Olema Pharmaceuticals, Inc. OLMA Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s accrued expenses?
- Olema Pharmaceuticals, Inc. (OLMA) reported accrued expenses of $42.49M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s accrued expenses changed year-over-year?
- Olema Pharmaceuticals, Inc.'s accrued expenses increased by 70.7% year-over-year, from $24.89M to $42.49M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Olema Pharmaceuticals, Inc.'s accrued expenses has grown at a 60.7% compound annual growth rate (CAGR), from $3.87M to $41.43M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.